Improves blood sugar control After eating, blood sugar rises, the digestive mucosa secretes incretin, also known as GLP-1 (Glucagon-like peptide 1), which has the function of regulating, increasing insulin secretion, and reducing blood sugar after eating
GLP-1RAs, including liraglutide and exendin-4, activate several signaling pathways that regulate bone formation and metabolism
Individuals with a personal or family history of medullary thyroid carcinoma or certain endocrine disorders should avoid GLP-1 therapy
Fifteen days after the treatment, all the mice were sacrificed and the tumorous tissue obtained (photographs of the tumor: Fig
(2) Supplement with -3 PUFAs (EPA + DHA 13 g/day) to inhibit the production of pro-inflammatory factors